Cargando…
17β‐estradiol reduces SARS‐CoV‐2 infection in vitro
The COVID‐19 has originated from Wuhan, China, in December 2019 and has been affecting the public health system, society, and economy in an unheard‐of manner. There is no specific treatment or vaccine available for COVID‐19. Previous data showed that men are more affected than women by COVID‐19, the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814496/ https://www.ncbi.nlm.nih.gov/pubmed/33463909 http://dx.doi.org/10.14814/phy2.14707 |
_version_ | 1783638066843353088 |
---|---|
author | Lemes, Robertha Mariana Rodrigues Costa, Angelica Jardim Bartolomeo, Cynthia Silva Bassani, Taysa Bervian Nishino, Michelle Sayuri Pereira, Gustavo Jose da Silva Smaili, Soraya Soubhi Maciel, Rui Monteiro de Barros Braconi, Carla Torres da Cruz, Edgar Ferreira Ramirez, Ana Lopez Maricatto, Juliana Terzi Janini, Luiz Mario Ramos Prado, Carla Máximo Stilhano, Roberta Sessa Ureshino, Rodrigo Portes |
author_facet | Lemes, Robertha Mariana Rodrigues Costa, Angelica Jardim Bartolomeo, Cynthia Silva Bassani, Taysa Bervian Nishino, Michelle Sayuri Pereira, Gustavo Jose da Silva Smaili, Soraya Soubhi Maciel, Rui Monteiro de Barros Braconi, Carla Torres da Cruz, Edgar Ferreira Ramirez, Ana Lopez Maricatto, Juliana Terzi Janini, Luiz Mario Ramos Prado, Carla Máximo Stilhano, Roberta Sessa Ureshino, Rodrigo Portes |
author_sort | Lemes, Robertha Mariana Rodrigues |
collection | PubMed |
description | The COVID‐19 has originated from Wuhan, China, in December 2019 and has been affecting the public health system, society, and economy in an unheard‐of manner. There is no specific treatment or vaccine available for COVID‐19. Previous data showed that men are more affected than women by COVID‐19, then we hypothesized whether sex hormones could be protecting the female organism against the infection. VERO E6 cells have been commonly used as in vitro model for SARS‐CoV‐2 infection. In our experimental approach, we have treated VERO E6 cells with 17β‐estradiol to evaluate the modulation of SARS‐CoV‐2 infection in this cell line. Here we demonstrated that estrogen protein receptors ERα, ERβ, and GPER1 are expressed by VERO E6 cells and could be used to study the effects of this steroid hormone. Previous and 24‐hours post‐infection, cells treated with 17β‐estradiol revealed a reduction in the viral load. Afterward, we found that SARS‐CoV‐2 infection per se results in ACE2 and TMPRSS2 increased gene expression in VERO E6‐cell, which could be generating a cycle of virus infection in host cells. The estrogen treatment reduces the levels of the TMPRSS2, which are involved with SARS‐CoV‐2 infectiveness capacity, and hence, reducing the pathogenicity/genesis. These data suggest that estrogen could be a potential therapeutic target promoting cell protection against SARS‐CoV‐2. This opens new possibilities for further studies on 17β‐estradiol in human cell lines infected by SARS‐CoV‐2 and at least in part, explain why men developed a more severe COVID‐19 compared to women. |
format | Online Article Text |
id | pubmed-7814496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78144962021-01-26 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro Lemes, Robertha Mariana Rodrigues Costa, Angelica Jardim Bartolomeo, Cynthia Silva Bassani, Taysa Bervian Nishino, Michelle Sayuri Pereira, Gustavo Jose da Silva Smaili, Soraya Soubhi Maciel, Rui Monteiro de Barros Braconi, Carla Torres da Cruz, Edgar Ferreira Ramirez, Ana Lopez Maricatto, Juliana Terzi Janini, Luiz Mario Ramos Prado, Carla Máximo Stilhano, Roberta Sessa Ureshino, Rodrigo Portes Physiol Rep Original Research The COVID‐19 has originated from Wuhan, China, in December 2019 and has been affecting the public health system, society, and economy in an unheard‐of manner. There is no specific treatment or vaccine available for COVID‐19. Previous data showed that men are more affected than women by COVID‐19, then we hypothesized whether sex hormones could be protecting the female organism against the infection. VERO E6 cells have been commonly used as in vitro model for SARS‐CoV‐2 infection. In our experimental approach, we have treated VERO E6 cells with 17β‐estradiol to evaluate the modulation of SARS‐CoV‐2 infection in this cell line. Here we demonstrated that estrogen protein receptors ERα, ERβ, and GPER1 are expressed by VERO E6 cells and could be used to study the effects of this steroid hormone. Previous and 24‐hours post‐infection, cells treated with 17β‐estradiol revealed a reduction in the viral load. Afterward, we found that SARS‐CoV‐2 infection per se results in ACE2 and TMPRSS2 increased gene expression in VERO E6‐cell, which could be generating a cycle of virus infection in host cells. The estrogen treatment reduces the levels of the TMPRSS2, which are involved with SARS‐CoV‐2 infectiveness capacity, and hence, reducing the pathogenicity/genesis. These data suggest that estrogen could be a potential therapeutic target promoting cell protection against SARS‐CoV‐2. This opens new possibilities for further studies on 17β‐estradiol in human cell lines infected by SARS‐CoV‐2 and at least in part, explain why men developed a more severe COVID‐19 compared to women. John Wiley and Sons Inc. 2021-01-19 /pmc/articles/PMC7814496/ /pubmed/33463909 http://dx.doi.org/10.14814/phy2.14707 Text en © 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Lemes, Robertha Mariana Rodrigues Costa, Angelica Jardim Bartolomeo, Cynthia Silva Bassani, Taysa Bervian Nishino, Michelle Sayuri Pereira, Gustavo Jose da Silva Smaili, Soraya Soubhi Maciel, Rui Monteiro de Barros Braconi, Carla Torres da Cruz, Edgar Ferreira Ramirez, Ana Lopez Maricatto, Juliana Terzi Janini, Luiz Mario Ramos Prado, Carla Máximo Stilhano, Roberta Sessa Ureshino, Rodrigo Portes 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro |
title | 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro |
title_full | 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro |
title_fullStr | 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro |
title_full_unstemmed | 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro |
title_short | 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro |
title_sort | 17β‐estradiol reduces sars‐cov‐2 infection in vitro |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814496/ https://www.ncbi.nlm.nih.gov/pubmed/33463909 http://dx.doi.org/10.14814/phy2.14707 |
work_keys_str_mv | AT lemesroberthamarianarodrigues 17bestradiolreducessarscov2infectioninvitro AT costaangelicajardim 17bestradiolreducessarscov2infectioninvitro AT bartolomeocynthiasilva 17bestradiolreducessarscov2infectioninvitro AT bassanitaysabervian 17bestradiolreducessarscov2infectioninvitro AT nishinomichellesayuri 17bestradiolreducessarscov2infectioninvitro AT pereiragustavojosedasilva 17bestradiolreducessarscov2infectioninvitro AT smailisorayasoubhi 17bestradiolreducessarscov2infectioninvitro AT macielruimonteirodebarros 17bestradiolreducessarscov2infectioninvitro AT braconicarlatorres 17bestradiolreducessarscov2infectioninvitro AT dacruzedgarferreira 17bestradiolreducessarscov2infectioninvitro AT ramirezanalopez 17bestradiolreducessarscov2infectioninvitro AT maricattojulianaterzi 17bestradiolreducessarscov2infectioninvitro AT janiniluizmarioramos 17bestradiolreducessarscov2infectioninvitro AT pradocarlamaximo 17bestradiolreducessarscov2infectioninvitro AT stilhanorobertasessa 17bestradiolreducessarscov2infectioninvitro AT ureshinorodrigoportes 17bestradiolreducessarscov2infectioninvitro |